SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-018168
Filing Date
2017-08-30
Accepted
2017-08-30 07:24:42
Documents
16
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 20-F 30 JUNE 2017 meso-20f_20170630.htm 20-F 10667391
2 EX-8.1 meso-ex81_144.htm EX-8.1 3999
3 EX-10 meso-ex10_181.htm EX-10 2677
4 EX-12.1 meso-ex121_143.htm EX-12.1 20336
5 EX-12.2 meso-ex122_142.htm EX-12.2 20456
6 EX-13.1 meso-ex131_141.htm EX-13.1 9836
7 EX-13.2 meso-ex132_139.htm EX-13.2 9897
8 EX-99.1 meso-ex991_140.htm EX-99.1 50943
9 EX-99.2 meso-ex992_528.htm EX-99.2 1476
10 GRAPHIC g20170830030003449163.jpg GRAPHIC 8454
11 GRAPHIC g20170830030003452164.jpg GRAPHIC 9723
12 GRAPHIC g20170830030003484165.jpg GRAPHIC 8293
13 GRAPHIC g20170830030003440161.jpg GRAPHIC 12381
14 GRAPHIC g20170830025952047160.jpg GRAPHIC 44986
15 GRAPHIC g20170830030003445162.jpg GRAPHIC 13449
16 GRAPHIC g20170830030003489166.jpg GRAPHIC 11716
  Complete submission text file 0001564590-17-018168.txt   10939287
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 001-37626 | Film No.: 171059243
SIC: 2836 Biological Products, (No Diagnostic Substances)